GSK plc
GLAXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $54,871 | $59,626 | $58,211 | $64,783 |
| - Cash | $3,693 | $2,936 | $3,723 | $4,274 |
| + Debt | $16,986 | $18,018 | $20,987 | $24,173 |
| Enterprise Value | $68,164 | $74,708 | $75,475 | $84,682 |
| Revenue | $31,376 | $30,328 | $29,324 | $34,114 |
| % Growth | 3.5% | 3.4% | -14% | – |
| Gross Profit | $22,328 | $21,763 | $19,770 | $22,511 |
| % Margin | 71.2% | 71.8% | 67.4% | 66% |
| EBITDA | $6,668 | $9,083 | $8,601 | $6,485 |
| % Margin | 21.3% | 29.9% | 29.3% | 19% |
| Net Income | $2,575 | $4,928 | $14,956 | $4,385 |
| % Margin | 8.2% | 16.2% | 51% | 12.9% |
| EPS Diluted | 0.62 | 1.2 | 3.66 | 1.35 |
| % Growth | -48.3% | -67.2% | 171.1% | – |
| Operating Cash Flow | $6,554 | $6,768 | $7,403 | $7,952 |
| Capital Expenditures | -$2,982 | -$2,344 | -$2,258 | -$2,931 |
| Free Cash Flow | $3,572 | $4,424 | $5,145 | $5,021 |